EUVIMEDEUVIMED entdecken
Crossref

Rational Optimization of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Inhibitors via Disruption of Molecular Planarity for Pulmonary Fibrosis

Zhi Cao, Shangfei Wei, Zhenhang Zhao, Lingfeng Yue, Youbao Cui, Sha Xu, Zehui Tan, Xin Zhai iD

Journal of Medicinal Chemistry · 11.06.2026 · 69 (11) · 13919-13940

DOI: 10.1021/acs.jmedchem.6c00982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.05.2026. Verfasst von Zhi Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: rho-Associated Kinases, Pulmonary Fibrosis, Protein Kinase Inhibitors. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, Liaoning Revitalization Talents Program, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the therapeutic potential of ROCK2 in pulmonary fibrosis (PF) and the significant efficacy of our previously identified lead compound 1, we initiated an optimization campaign focused on addressing physicochemical liabilities through disrupting molecular planarity. By implementing “sp3-rich” and “magic methyl” strategies, two series of ROCK2 inhibitors featuring 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine or imidazo[1,2-b]pyridazine scaffolds were developed. A dedicated evaluation discovered the optimal compound 39, which exhibited potent ROCK2 inhibition (IC50 = 0.0081 μM), enhanced kinetic solubility (77 μg/mL in water), improved metabolic stability (t1/2 = 5.0 h for p.o), favorable kinase selectivity, and an acceptable safety profile. Notably, 39 effectively suppressed TGF-β1-induced fibroblast activation and migration, while significantly attenuating bleomycin-induced PF in vivo. Moreover, mechanistic studies revealed that the antifibrotic effects of 39 were mediated through inhibition of the TGF-β/Smad and ROCK2/STAT3 signaling pathways. Overall, these findings validate the proposed design strategy and deliver a novel candidate for ROCK2-targeted therapy in PF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

rho-Associated KinasesPulmonary FibrosisProtein Kinase InhibitorsAnimalsHumansStructure-Activity RelationshipMiceBleomycinFibroblastsSignal TransductionCell Movement

Substanzen

rho-Associated KinasesProtein Kinase InhibitorsROCK2 protein, humanBleomycin

Autor:innen und Institutionen

  • Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.

ORCID-Profile: Xin Zhai

Förderung

  • Ministry of Education of the People's Republic of China
  • Liaoning Revitalization Talents Program
  • China Postdoctoral Science Foundation

Zitieren

APA

Cao, Z., Wei, S., Zhao, Z., Yue, L., Cui, Y., Xu, S., Tan, Z., & Zhai, X. (2026). Rational Optimization of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Inhibitors via Disruption of Molecular Planarity for Pulmonary Fibrosis. Journal of Medicinal Chemistry, 69(11), 13919-13940. https://doi.org/10.1021/acs.jmedchem.6c00982

Vancouver

Cao Z, Wei S, Zhao Z, Yue L, Cui Y, Xu S, et al. Rational Optimization of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Inhibitors via Disruption of Molecular Planarity for Pulmonary Fibrosis. Journal of Medicinal Chemistry. 2026;69(11):13919-13940. doi:10.1021/acs.jmedchem.6c00982

BibTeX
@article{Cao2026,
  author = {Cao, Zhi and Wei, Shangfei and Zhao, Zhenhang and Yue, Lingfeng and Cui, Youbao and Xu, Sha and Tan, Zehui and Zhai, Xin},
  title = {Rational Optimization of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Inhibitors via Disruption of Molecular Planarity for Pulmonary Fibrosis},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {11},
  pages = {13919--13940},
  doi = {10.1021/acs.jmedchem.6c00982}
}
Kostenlos starten →